Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 1;6(8):e2328950.
doi: 10.1001/jamanetworkopen.2023.28950.

Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak

Collaborators, Affiliations

Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak

Natasha Halasa et al. JAMA Netw Open. .

Erratum in

  • Errors in Figure 2, Results, and Tables 1 and 2.
    [No authors listed] [No authors listed] JAMA Netw Open. 2024 Jul 1;7(7):e2428669. doi: 10.1001/jamanetworkopen.2024.28669. JAMA Netw Open. 2024. PMID: 39052300 Free PMC article. No abstract available.

Abstract

Importance: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections (LRTIs) and infant hospitalization worldwide.

Objective: To evaluate the characteristics and outcomes of RSV-related critical illness in US infants during peak 2022 RSV transmission.

Design, setting, and participants: This cross-sectional study used a public health prospective surveillance registry in 39 pediatric hospitals across 27 US states. Participants were infants admitted for 24 or more hours between October 17 and December 16, 2022, to a unit providing intensive care due to laboratory-confirmed RSV infection.

Exposure: Respiratory syncytial virus.

Main outcomes and measures: Data were captured on demographics, clinical characteristics, signs and symptoms, laboratory values, severity measures, and clinical outcomes, including receipt of noninvasive respiratory support, invasive mechanical ventilation, vasopressors or extracorporeal membrane oxygenation, and death. Mixed-effects multivariable log-binomial regression models were used to assess associations between intubation status and demographic factors, gestational age, and underlying conditions, including hospital as a random effect to account for between-site heterogeneity.

Results: The first 15 to 20 consecutive eligible infants from each site were included for a target sample size of 600. Among the 600 infants, the median (IQR) age was 2.6 (1.4-6.0) months; 361 (60.2%) were male, 169 (28.9%) were born prematurely, and 487 (81.2%) had no underlying medical conditions. Primary reasons for admission included LRTI (594 infants [99.0%]) and apnea or bradycardia (77 infants [12.8%]). Overall, 143 infants (23.8%) received invasive mechanical ventilation (median [IQR], 6.0 [4.0-10.0] days). The highest level of respiratory support for nonintubated infants was high-flow nasal cannula (243 infants [40.5%]), followed by bilevel positive airway pressure (150 infants [25.0%]) and continuous positive airway pressure (52 infants [8.7%]). Infants younger than 3 months, those born prematurely (gestational age <37 weeks), or those publicly insured were at higher risk for intubation. Four infants (0.7%) received extracorporeal membrane oxygenation, and 2 died. The median (IQR) length of hospitalization for survivors was 5 (4-10) days.

Conclusions and relevance: In this cross-sectional study, most US infants who required intensive care for RSV LRTIs were young, healthy, and born at term. These findings highlight the need for RSV preventive interventions targeting all infants to reduce the burden of severe RSV illness.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Halasa reported receiving grants from Sanofi, Quidel, and Merck outside the submitted work. Dr Levy reported receiving grants from the National Institute of Allergy and Infectious Diseases, Centers of Excellence for Influenza Research and Response, and the Health Resources and Services Administration Regional Pandemic Pediatric Network outside the submitted work. Dr Fitzgerald reported receiving grants from the National Institutes of Health (NIH) outside the submitted work. Dr Cullimore reported receiving grants from the Centers for Disease Control and Prevention (CDC) and grants from the NIH outside the submitted work; and financial compensation for a minor child to participate in a clinical trial funded by industry. Dr Pannaraj reported receiving grants from AstraZeneca outside the submitted work. Dr Cvijanovich reported receiving grants from Boston Children’s Hospital Subaward during the conduct of the study; grants from Cincinnati Children’s Hospital Subaward and grants from the National Institute of Child Health and Human Development (NICHD) outside the submitted work. Dr Maddux reported receiving grants from the NIH/NICHD during the conduct of the study. Dr Bembea reported receiving grants from the NIH, Department of Defense funds paid to the institution, and grants from Grifols Investigator Sponsored Research paid to the institution outside the submitted work. Dr Zerr reported receiving grants from Boston Children’s Hospital/CDC during the conduct of the study; grants from Merck investigator-initiated research on RSV and industry-sponsored research for several different protocols, and personal fees from Allovir Service outside the submitted work. Dr Kong reported receiving grants from the NIH outside the submitted work. Dr Coates reported receiving grants from American Lung Association and grants from American Thoracic Society outside the submitted work. Dr Hobbs reported receiving personal fees from DYNAMED.com clinical database and reviewer and personal fees from Biofire/Biomerieux (2021-2022) outside the submitted work. Dr Rowan reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) outside the submitted work. Dr Wellnitz reported receiving grants from the NHLBI and the NIH outside the submitted work. Dr Staat reported receiving grants from the NIH outside the submitted work. Dr Aguiar reported receiving funding from the CDC to primary institution outside the submitted work. Dr Randolph reported receiving grants from the NIH to institution outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Signs and Symptoms in Infants Requiring Intensive Care for Respiratory Syncytial Virus Infection
Figure 2.
Figure 2.. Factors Associated With Risk for Intubation in Infants Requiring Intensive Care for Respiratory Syncytial Virus Infection
PR indicates prevalence ratio.

References

    1. Shi T, Balsells E, Wastnedge E, et al. . Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis. J Glob Health. 2015;5(2):020416. doi:10.7189/jogh.05.020416 - DOI - PMC - PubMed
    1. Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. . Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356-1364. doi:10.1093/infdis/jiy056 - DOI - PubMed
    1. Hall CB, Weinberg GA, Iwane MK, et al. . The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588-598. doi:10.1056/NEJMoa0804877 - DOI - PMC - PubMed
    1. Suh M, Movva N, Jiang X, et al. . Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009-2019: a study of the national (nationwide) inpatient sample. J Infect Dis. 2022;226(suppl 2):S154-S163. doi:10.1093/infdis/jiac120 - DOI - PMC - PubMed
    1. Rha B, Curns AT, Lively JY, et al. . Respiratory syncytial virus-associated hospitalizations among young children: 2015-2016. Pediatrics. 2020;146(1):e20193611. doi:10.1542/peds.2019-3611 - DOI - PubMed